![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/506 | (2006.01) |
A61K 31/70 | (2006.01) | ||
A61K 31/7042 | (2006.01) | ||
A61K 31/7048 | (2006.01) | ||
A61K 31/7056 | (2006.01) | ||
A61P 9/10 | (2006.01) | ||
A61P 17/02 | (2006.01) | ||
A61P 13/12 | (2006.01) | ||
A61P 9/12 | (2006.01) | ||
A61P 3/10 | (2006.01) |
(11) | Number of the document | 3716979 |
(13) | Kind of document | T |
(96) | European patent application number | 18814821.7 |
Date of filing the European patent application | 2018-11-29 | |
(97) | Date of publication of the European application | 2020-10-07 |
(45) | Date of publication and mention of the grant of the patent | 2025-04-09 |
(46) | Date of publication of the claims translation | 2025-07-10 |
(86) | Number | PCT/EP2018/082947 |
Date | 2018-11-29 |
(87) | Number | WO 2019/106066 |
Date | 2019-06-06 |
(30) | Number | Date | Country code |
PCT/EP2017/081050 | 2017-11-30 | WO |
(72) |
BELLET, Marc , CH
IGLARZ, Marc , CH
|
(73) |
Idorsia Pharmaceuticals Ltd ,
Hegenheimermattweg 91, 4123 Allschwil,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 4-pirimidinsulfamido darinio derinys su SGLT-2 inhibitoriumi, skirtas su endotelinu susijusių ligų gydymui |
COMBINATION OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH AN SGLT-2 INHIBITOR FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES |